Glucose–insulin feedback can reactivate PI3K in tumours treated with PI3K inhibitors, reducing therapeutic efficacy, but this effect can be reduced by using drugs or diet to suppress the insulin response.
- Benjamin D. Hopkins
- Chantal Pauli
- Lewis C. Cantley
